Ignite Creation Date:
2024-07-17 @ 11:19 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06481228
Status:
RECRUITING
Last Update Posted:
2024-07-01
First Post:
2024-05-24
Brief Title:
Efficacy and Safety of TKI Combined With Chemotherapy and Sequential CAR-T Cells in ND Adult Patients With Ph ALL
Sponsor:
Institute of Hematology Blood Diseases Hospital China
Organization:
Institute of Hematology Blood Diseases Hospital China
Organization Data
Organization:
Institute of Hematology Blood Diseases Hospital China
Class:
OTHER
Study ID:
IIT2024019
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Institute of Hematology Blood Diseases Hospital China
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None